wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28075504-5A072019-5595-4B1F-928B-F5E473B33CE6
Q28075504-5A072019-5595-4B1F-928B-F5E473B33CE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075504-5A072019-5595-4B1F-928B-F5E473B33CE6
The potential of venetoclax (ABT-199) in chronic lymphocytic leukemia
P2860
Q28075504-5A072019-5595-4B1F-928B-F5E473B33CE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075504-5A072019-5595-4B1F-928B-F5E473B33CE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b64a681dfefcbcfb7f5effa7301e50179e6d7a3b
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies